Description: Tetra Bio Pharma Inc is a Canada-based company engaged in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements. The Company is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. The Company objective is to bring smokable, natural medical marijuana to the market along with a number of other products targeting chronic pain, insomnia, post-traumatic stress disorder (PTSD), anxiety, among others. The Company operates through three divisions: PhytoPain Pharma Inc, Agro Tek Health and Grow Pros Cannabis Ventures Inc.
Home Page: www.tetrabiopharma.com
TBP Technical Analysis
2316 St. Joseph Boulevard
Orléans,
ON
K1C 1E8
Canada
Phone:
343 780 2020
Officers
| Name | Title |
|---|---|
| Dr. Guy Chamberland M.Sc., Master Herbal | Co-Founder, CEO, Chief Regulatory Officer & Director |
| Mr. Steeve Néron | Chief Commercial Officer |
| Mr. André Rancourt B.Sc. | Co-Founder |
| Ms. Leslie Auld CPA, M.B.A. | Chief Financial Officer |
| Dr. Melanie Edna Mary Kelly Ph.D. | Chief Scientific Officer |
| Jennifer McCaughey | VP of Investor Relations |
| Ms. Dania Scott B.Sc. | Sr. VP of Commercial Strategy |
| Ms. Aurelia De Pauw | Sr. VP of Clinical Programs & Medical Affairs |
| Mr. Richard Giguere | Chief Exec. Officer of Tetra Natural Health Inc. |
| Randy Ringuette | Project Director & Member of Advisory Board |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 48.203 |
| Price-to-Sales TTM: | 659.0048 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 33 |